vs
Side-by-side financial comparison of iQIYI, Inc. (IQ) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $971.6M, roughly 1.5× iQIYI, Inc.).
iQIYI, Inc.IQEarnings & Financial Report
iQIYI, formerly Qiyi, is a Chinese subscription video on-demand over-the-top streaming service owned by Baidu. Headquartered in Beijing, iQIYI primarily produces and distributes films and television series.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
IQ vs ONC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $971.6M | $1.5B |
| Net Profit | — | $66.5M |
| Gross Margin | — | 90.5% |
| Operating Margin | 0.8% | 12.4% |
| Net Margin | — | 4.4% |
| Revenue YoY | — | 32.8% |
| Net Profit YoY | — | 143.8% |
| EPS (diluted) | — | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $971.6M | — | ||
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | $906.0M | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $929.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $66.5M | ||
| Q3 25 | — | $124.8M | ||
| Q2 25 | — | $94.3M | ||
| Q1 25 | — | $1.3M | ||
| Q4 24 | — | $-151.9M | ||
| Q3 24 | — | $-121.3M | ||
| Q2 24 | — | $-120.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% |
| Q1 26 | 0.8% | — | ||
| Q4 25 | — | 12.4% | ||
| Q3 25 | — | 11.5% | ||
| Q2 25 | — | 6.7% | ||
| Q1 25 | 4.3% | 1.0% | ||
| Q4 24 | — | -7.0% | ||
| Q3 24 | — | -12.0% | ||
| Q2 24 | — | -11.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.4% | ||
| Q3 25 | — | 8.8% | ||
| Q2 25 | — | 7.2% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | -13.5% | ||
| Q3 24 | — | -12.1% | ||
| Q2 24 | — | -13.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | $0.05 | ||
| Q3 25 | — | $0.08 | ||
| Q2 25 | — | $0.06 | ||
| Q1 25 | — | $0.00 | ||
| Q4 24 | — | $-0.10 | ||
| Q3 24 | — | $-0.09 | ||
| Q2 24 | — | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.4M | $4.5B |
| Total DebtLower is stronger | — | $836.4M |
| Stockholders' EquityBook value | $13.3M | $4.4B |
| Total Assets | $46.7M | $8.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $4.4M | — | ||
| Q4 25 | — | $4.5B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | $3.5M | $2.5B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | — | $2.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | $836.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $13.3M | — | ||
| Q4 25 | — | $4.4B | ||
| Q3 25 | — | $4.1B | ||
| Q2 25 | — | $3.8B | ||
| Q1 25 | $13.4M | $3.5B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | — | $3.4B | ||
| Q2 24 | — | $3.4B |
| Q1 26 | $46.7M | — | ||
| Q4 25 | — | $8.2B | ||
| Q3 25 | — | $7.6B | ||
| Q2 25 | — | $6.3B | ||
| Q1 25 | $45.8M | $5.8B | ||
| Q4 24 | — | $5.9B | ||
| Q3 24 | — | $5.8B | ||
| Q2 24 | — | $5.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $417.3M |
| Free Cash FlowOCF − Capex | — | $379.8M |
| FCF MarginFCF / Revenue | — | 25.4% |
| Capex IntensityCapex / Revenue | — | 2.5% |
| Cash ConversionOCF / Net Profit | — | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $417.3M | ||
| Q3 25 | — | $402.6M | ||
| Q2 25 | — | $263.6M | ||
| Q1 25 | — | $44.1M | ||
| Q4 24 | — | $75.2M | ||
| Q3 24 | — | $188.4M | ||
| Q2 24 | — | $-95.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $379.8M | ||
| Q3 25 | — | $354.5M | ||
| Q2 25 | — | $219.8M | ||
| Q1 25 | — | $-12.3M | ||
| Q4 24 | — | $-17.3M | ||
| Q3 24 | — | $54.7M | ||
| Q2 24 | — | $-205.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 25.4% | ||
| Q3 25 | — | 25.1% | ||
| Q2 25 | — | 16.7% | ||
| Q1 25 | — | -1.1% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | -22.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.5% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 5.0% | ||
| Q4 24 | — | 8.2% | ||
| Q3 24 | — | 13.3% | ||
| Q2 24 | — | 11.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.28× | ||
| Q3 25 | — | 3.22× | ||
| Q2 25 | — | 2.79× | ||
| Q1 25 | — | 34.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
